Sort
50,496 grants matching “lung cancer”
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$420,375Roberto Chiarle · Boston Children'S Hospital · R01 · FY2025 · CA
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis
$420,347Fung-Lung Chung · Georgetown University · R01 · FY2011 · CA
Phenotype Interactions and Dynamics in SCLC Tumors
$420,340Alissa M Weaver · Vanderbilt University · U54 · FY2022 · CA
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array
$420,331Margaret Elisabeth Huflejt · New York University School Of Medicine · U01 · FY2010 · CA
FRESH: Dual Home Screening for Lung Cancer Prevention
$420,326Ellen J Hahn · University Of Kentucky · R01 · FY2014 · ES
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$420,270David M. Ashley · Duke University · U19 · FY2025 · CA
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies
$420,196Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Developmental Funds
$420,175Edward Chu · Albert Einstein College Of Medicine · P30 · FY2023 · CA
IP-10 Chemokine: Role in T Cell Recruitment and Disease
$420,153Massachusetts General Hospital · R01 · FY2005 · CA
Hexokinase 2 in liver cancer
$420,150Nissim Hay · University Of Illinois At Chicago · R01 · FY2019 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$420,140Ming Hui Chen · Duke University · R01 · FY2025 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$420,140Ming Hui Chen · Duke University · R01 · FY2022 · CA
VASCULAR, PULMONARY AND RENAL INJURY
$420,133Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2009 · HL
GRPR Signaling in SCCHN: Integration with EGFR
$420,100University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Nicotine, nicotinic receptors and lung cancer
$420,054Eliot R Spindel · Oregon Health & Science University · R01 · FY2013 · CA
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
$420,053Jane B Lian · University Of Vermont & St Agric College · P01 · FY2022 · CA
Development of a Novel TGF-beta Antagonist for Treating Hepatic Fibrosis
$420,003Jung S. Huang · Saint Louis University · RC1 · FY2010 · AA
Sorting of Plasma Membrane Proteins in Epithelial Cells
$420,000Enrique J Rodriguez-Boulan · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · GM
Amnis ImageStream Analyzer
$420,000Anne I. Sperling · University Of Chicago · S10 · FY2010 · RR
Basis for Lymphomagenesis in Akt2 Transgenic Mice
$419,987Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2011 · CA
Identifying Genes that Cause Lung Cancer to Progress
$419,910California Pacific Med Ctr Res Institute · R01 · FY2003 · CA
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$419,852Kwon-Sik Park · University Of Virginia · U01 · FY2019 · CA
Skeletal Muscle Atrophy and Dysfunction in Human Cancer
$419,836Michael J Toth · University Of Vermont & St Agric College · R01 · FY2017 · AR
Clinical models for evaluating PREPs for tobacco users
$419,821Thomas Evan Eissenberg · Virginia Commonwealth University · R01 · FY2007 · CA
SBIR Phase II: High throughput screening for splice variant cDNAs
$419,813Jean-Michel A Lelias · Genofi, Llc · R44 · FY2008 · HG